{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:11:17Z","timestamp":1789593077689,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.pathol.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:04:09Z","timestamp":1783119849000},"page":"707-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Applicability of the WHO grading for reticulin and collagen fibrosis in a routine diagnostic laboratory"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9215-1441","authenticated-orcid":false,"given":"Zoe","family":"Loh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Khoon","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2026.06.005_bib1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12967-023-04393-z","article-title":"Fibrosis and bone marrow: understanding causation and pathobiology","volume":"21","author":"Ghosh","year":"2023","journal-title":"J Trans Med"},{"key":"10.1016\/j.pathol.2026.06.005_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.26502\/fccm.92920302","article-title":"Regulation of collagen I and collagen III in tissue injury and regeneration","volume":"7","author":"Singh","year":"2023","journal-title":"Cardiol Cardiovasc Med"},{"key":"10.1016\/j.pathol.2026.06.005_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2141.2007.06807.x","article-title":"Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres","volume":"139","author":"Kuter","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2026.06.005_bib4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00277-005-0042-8","article-title":"Grade of bone marrow fibrosis is associated with relevant hematological findings\u2013a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis","volume":"85","author":"Thiele","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1016\/j.pathol.2026.06.005_bib5","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/modpathol.2012.87","article-title":"The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis","volume":"25","author":"Gianelli","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2026.06.005_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/j.seminoncol.2005.04.010","article-title":"Hematopathologic findings in chronic idiopathic myelofibrosis","volume":"32","author":"Thiele","year":"2005","journal-title":"Semin Oncol"},{"key":"10.1016\/j.pathol.2026.06.005_bib7","volume":"Vol. 11","year":"2024"},{"key":"10.1016\/j.pathol.2026.06.005_bib8","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2016"},{"key":"10.1016\/j.pathol.2026.06.005_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ajcp\/56.1.24","article-title":"Quantitation of bone marrow reticulin\u2014a normal range","volume":"56","author":"Bauermeister","year":"1971","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2026.06.005_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.1979.tb03740.x","article-title":"The reticulin content of bone marrow in acute leukaemia in adults","volume":"43","author":"Manoharan","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2026.06.005_bib11","first-page":"1128","article-title":"European Consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematology"},{"key":"10.1016\/j.pathol.2026.06.005_bib12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/his.12871","article-title":"Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis \u2013 a consensus-based study","volume":"68","author":"Kvasnicka","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2026.06.005_bib13","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/modpathol.2014.69","article-title":"High concordance in grading reticulin fibrosis and cellularity in patients with myeloproliferative neoplasms","volume":"27","author":"Pozdnyakova","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2026.06.005_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2007-05-091850","article-title":"Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes","volume":"111","author":"Wilkins","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2026.06.005_bib15","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ajh.23554","article-title":"World Health Organization-defined classification of myeloproliferative neoplasms: morphological reproducibility and clinical correlations\u2014the Danish experience","volume":"88","author":"Madelung","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2026.06.005_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pathol.2023.09.012","article-title":"Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registry","volume":"56","author":"Ng","year":"2024","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2026.06.005_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41375-022-01773-0","article-title":"Continuous indexing of fibrosis (CIF): improving the assessment and classification of MPN patients","volume":"37","author":"Ryou","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2026.06.005_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.70005","article-title":"Reticulin-free quantitation of bone marrow fibrosis in MPNs: utility and applications","volume":"6","author":"Ryou","year":"2025","journal-title":"eJHaem"},{"key":"10.1016\/j.pathol.2026.06.005_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12967-022-03366-y","article-title":"Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1\/2","volume":"20","author":"Song","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.pathol.2026.06.005_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jha2.854","article-title":"Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis","volume":"5","author":"Oh","year":"2024","journal-title":"eJHaem"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526005714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526005714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:57:44Z","timestamp":1789592264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302526005714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0031302526005714"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2026.06.005","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applicability of the WHO grading for reticulin and collagen fibrosis in a routine diagnostic laboratory","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}